Search

Breast cancer cells have long been inhibited by polypyridine Ru(II) complexes, which are excellent antitumor agents. Due to their multi-targeting properties, this class of ruthenium complexes has received increasing attention as anticancer drug candidates approach to various cellular targets. The aim of this review is to give information about the ligands that were carefully chosen for ruthenium complexes. There has been a great deal of interest in using ruthenium-based complexes to treat breast cancer. Several species have shown potential as treatment candidates. However, further research is needed to determine how these agents affect the metastatic potential of breast cancer cells. The mechanism of action of Ru-based anticancer candidates NAMI-A and KP1019 during phase I clinical trials has been discussed. This article explains hormone-positive breast cancer and triple-negative breast-cancer treatment by using Ru complexes. Although platinum (Pt-based) anticancer medication is widely used in cancer treatment, a minor improvement has been seen and that is Platinum replaced with Ruthenium for its anticancer properties. We have also highlighted the best effective ruthenium-based complexes in treating T.N.B.C. (triple-negative breast cancer) here in this collection. [ABSTRACT FROM AUTHOR]

Abstract: A new Hg(II)–N-heterocyclic carbene (NHC) complex (1) of the form [(NHC)2-μ-Hg]·2PF6 was synthesized from the reaction of Hg(II) acetate with a meta-xylyl-linked bis-imidazolium salt (η1-areneC–H model). The complex was characterized using elemental analysis, nuclear magnetic resonance (1H, 13C and HMQC), and single-crystal X-ray diffraction techniques. X-ray structural studies on complex 1 revealed a linear coordination of the Hg ion with both carbene centers of the ligand. In addition, a strong interaction between the Hg ion and a carbon atom of the aryl ring of the ligand was also observed. This interesting interaction is further supported by a downfield chemical shift of the 1H NMR signal for the arene-H that interacts with mercury (δ 0.88 compared to the free ligand). In a related meta-arylene-bis(imidazol-2-yliden-1-ylmethyl) Hg(II) complex (2) with a methyl group between the bridges, synthesized in analogy to complex 1, no such interaction between the Hg ion and the aryl ring was observed. [Copyright &y& Elsevier]

Schiff bases have proven to be beneficial in medicine and have interesting complexation capabilities with transition metals. The +4, +5, and +6 oxidation states of schiff base metal complexes have been the subject of recent review, which have highlighted their notable cytotoxic effects against various colon cancer cell lines (HT-29, HCT-116, SW-480, Coco-2, CT-26, LT-174, LoVo). Extensive research has focused on schiff base metal complexes in the +4 and +6 oxidation states, exhibiting distinct geometries and significant thermodynamic stability. These studies provide IC50 values for these complexes in colon cancer cell lines along with comprehensive structural representations that shed light on how different substituents affect cytotoxicity. When compared to schiff base ligands alone, metal complexes of schiff bases have been shown to significantly reduce colon cancer cell invasion and proliferation. The studied literature emphasizes schiff base metal complexe’s potential in biological applications and suggests that more study may be necessary to fully comprehend their biology. To enable more sophisticated multidisciplinary study in this field, future investigations should focus on synthesizing novel complexes with enhanced bioavailability, solubility, and low toxicity. [ABSTRACT FROM AUTHOR]

The present review deeply delves the major methods for the synthesis of organotellurium compounds along with their biological significance. Elaboration of various precursors (ligands) including Schiff bases, naphthoquinones, amino acids, β-hydroxy alkylated compounds, β-phenyltelluro alcohols, β-aryltelluro amines, β-aryl-chalcogenium azides, chalcogenobiotin, benzenesulfonamide, carbonic anhydrase, and Sulpha compounds has been briefly described. Furthermore, the article investigates their possible biological uses, specifically as antioxidant and anticancer agents while comparing their effectiveness with their respective ligands and with the standard medications in terms IC50 values. All types of details are haunted to make the information a priceless resource for researchers who wish to probe deeper into and examine the diverse roles that organotellurium complexes play in biological settings. [ABSTRACT FROM AUTHOR]

In the title compound, C(12)H(12)N(3) (+)·PF(6) (-), the hexa-fluoro-phosphate anion is disordered over two orientations with refined site occupancies of 0.8071 (17) and 0.1929 (17). The dihedral angle between the imidazole and benzene rings in the cation is 71.26 (7)°. In the crystal, the cations and anions are linked by C-H⋯F and C-H⋯N hydrogen bonds into a three-dimensional network.

The asymmetric unit of the title complex, [Hg(C(11)H(12)N(2))(2)](PF(6))(2), consists of one bis-(1-benzyl-3-methyl-imidazolium)mercury(II) cation, one half of the cation and an additional Hg(II) atom, which lies on an inversion centre, and three hexa-fluorido-phosphate anions. The Hg(II) atoms exist in a linear coordination geometry [C-Hg-C = 178.9 (2) and 180°] formed by two carbene C atoms from the imidazole rings. In the crystal, the cations and anions are connected via C-H⋯F hydrogen bonds, forming a three-dimensional network.

In the title molecular salt, C(31)H(34)N(4) (2+)·2Br(-), the central benzene ring makes dihedral angles of 80.47 (12) and 82.78 (12)° with the adjacent imidazole rings. The dihedral angle between the two terminal phenyl rings is 79.16 (13)°. In the crystal, the cations and anions are linked via C-H⋯Br hydrogen bonds, forming supra-molecular chains along the c axis.

In the title molecular salt, C(25)H(38)N(4) (2+)·2PF(6) (-), one of the butyl groups and four F atoms in the basal plane of one of the PF(6) (-) octa-hedra are disordered over two sets of sites, with occupancy ratios of 0.704 (5):0.296 (5) and 0.71 (3):0.29 (3), respectively. The central benzene ring makes dihedral angles of 85.17 (12) and 81.97 (12)° with the terminal imidazole rings. In the crystal, cations and anions are linked together via inter-molecular C-H⋯F hydrogen bonds forming a three-dimensional network.

In the title compound, K[Ag(C(11)H(12)N(2))(2)](2)(PF(6))(3), the 12-coordinate potassium cation lies on a crystallographic twofold axis and one of the hexa-fluoro-phosphate anions is generated by symmetry. In the complex cation, the Ag(I) ion is coordinated by two C atoms; the two imidazolium rings are orientated at a dihedral angle of 8.14 (14)°. In the 1-benzyl-3-methyl-imidazolium units, the dihedral angles between imidazolium and phenyl rings are 80.47 (15) and 76.53 (14)°. The F atoms of the general-position hexa-fluoro-phosphate anion are disordered over two sets of sites in a 0.767 (17):0.233 (17) ratio. In the crystal, the hexa-fluoro-phosphate anions link the cations into three-dimensional networks via inter-molecular C-H⋯F hydrogen bonds and are further consolidated by π-π stacking [centroid-centroid distances = 3.5518 (15) Å] inter-actions.